Panel of Judges
Partner, Consonance Capital Partners
Nancy-Ann DeParle is a partner at Consonance Capital Partners, a private equity fund that invests in innovative health care companies in the lower middle-market. Previously, she was President Barack Obama's Deputy Chief of Staff for Policy and led the President's successful effort to enact the Affordable Care Act and managed the initial implementation of the law. She is a Director of CVS Health and Hospital Corporation of America (HCA).
From 2006-2009, DeParle was a Managing Director of CCMP Capital Advisors, a private equity firm, and a senior advisor to its predecessor, JPMorgan Partners, LLC. She was also a Senior Fellow at the Wharton School of the University of Pennsylvania and a trustee or director of several corporate and non-profit boards. DeParle was Administrator of the agency now known as the Centers for Medicare and Medicaid Services (CMS), from 1997-2000. She directed Medicare, Medicaid, and State Children’s Health Insurance (SCHIP), which provides health insurance for more than 105 million Americans at an annual cost of $870 billion. Earlier in her career, she served as Associate Director for Health and Personnel at the White House Office of Management and Budget (OMB), and Commissioner of the Tennessee Department of Human Services.
DeParle has been a lecturer in law at Harvard Law School and a Guest Scholar at the Brookings Institution. She received a BA with highest honors from the University of Tennessee, and a JD from Harvard Law School. She also received a BA and MA in Politics and Economics from Balliol College of Oxford University, where she was a Rhodes Scholar.
A. Mark Fendrick, MD
Professor of Internal Medicine in the School of Medicine
Professor of Health Management and Policy in the School of Public Health at the University of Michigan
Dr. Fendrick is a Professor of Internal Medicine in the School of Medicine and a Professor of Health Management and Policy in the School of Public Health at the University of Michigan. Dr. Fendrick conceptualized and coined the term Value-Based Insurance Design (V-BID) and currently directs the V-BID Center at the University of Michigan, the leading advocate for development, implementation, and evaluation of innovative health benefit plans. His research focuses on how clinician payment and consumer engagement initiatives impact access to care, quality of care, and health care costs.
Dr. Fendrick has authored over 250 articles and book chapters and has received numerous awards for the creation and implementation of value-based insurance design. His perspective and understanding of clinical and economic issues have fostered collaborations with numerous government agencies, health plans, professional societies, and health care companies. Dr. Fendrick is an elected member of the Institute of Medicine of the National Academy of Sciences, serves on the Medicare Coverage Advisory Committee, and has been invited to present testimony before the U.S. Senate Committee on Health, Education, Labor and Pensions and the U.S. House of Representatives Ways and Means Subcommittee on Health.
Dr. Fendrick is the co-editor in chief of the American Journal of Managed Care and is an editorial board member for 3 additional peer-reviewed publications. He is also a member of the Institute for Healthcare Policy and Innovation at the University of Michigan, where he remains clinically active in the practice of general internal medicine.
Dr. Fendrick received a bachelor’s degree in economics and chemistry from the University of Pennsylvania and his medical degree from Harvard Medical School. He completed his residency in internal medicine at the University of Pennsylvania where he was a fellow in the Robert Wood Johnson Foundation Clinical Scholars Program.
Tejal K. Gandhi, MD, MPH, CPPS
President and Chief Executive Officer of the National Patient Safety Foundation (NPSF)
Dr. Gandhi is President and Chief Executive Officer of the National Patient Safety Foundation (NPSF), the NPSF Lucian Leape Institute, and the Certification Board for Professionals in Patient Safety. She advocates for patient safety at the national level by driving educational and professional certification efforts, and helping to create and spread innovative new safety ideas. Dr. Gandhi was formerly the Executive Director of Quality and Safety at Brigham and Women’s Hospital, and Chief Quality and Safety Officer at Partners Healthcare. In these roles, she led the efforts to standardize and implement patient safety best practices across hospital and health systems.
Throughout her career, Dr. Gandhi has been committed to educating other clinicians on the topic of patient safety. She has been an invited speaker for numerous organizations, has mentored physicians in post-doctoral study, and has frequently served on national and regional committees and boards. She was included in Modern Healthcare’s 100 Most Influential People in Healthcare in 2014 and 2015 and was also one of their 2015 Top 25 Women in Healthcare.
Dr. Gandhi’s research interests focus on patient safety and reducing error using information systems. In 2009, she received the John M. Eisenberg Patient Safety and Quality Award for her contributions to understanding the epidemiology and possible prevention strategies for medical errors in the outpatient setting.
Dr. Gandhi is a board certified internist and Associate Professor of Medicine at Harvard Medical School, and she is a Certified Professional in Patient Safety. She received her MD and MPH from Harvard Medical School and the Harvard School of Public Health, and trained at Duke University Medical Center. Her undergraduate training at Cornell University was in biochemistry.
H. Stephen Lieber, CAE
President and Chief Executive Officer of HIMSS
Mr. Lieber has served as President and Chief Executive Officer of HIMSS (Healthcare Information and Management Systems Society) and related organizations for over 15 years. HIMSS consists of HIMSS and HIMSS International, cause-based, global membership societies; HIMSS Analytics, the market research and data services group; and HIMSS Media, the diversified media and publishing division, and PCHA, The Personal Connected Health Alliance—all focused on better health through information technology. In his strategic leadership role at HIMSS, Lieber has established the organization as a global leader on issues such as, electronic health records, interoperability, technology standards, IT adoption, and certification.
A seasoned healthcare management executive, Lieber has over 30 years of experience. In addition to his service on the Board of Directors of HIMSS and its related corporations, he serves on a number of corporate, non-profit and coalition boards and groups. He was one of the founders of the Certification Commission for HIT and the Health Information Technology Standards Panel, two U.S. federally funded initiatives at the foundation of the U.S. interoperability effort.
As a nationally recognized commentator on health policy, in general, and specifically on healthcare IT trends and issues, Lieber is a regular speaker and contributor to corporate strategic planning efforts, government-sponsored policy efforts, private sector initiatives and other non-profit organizations. Lieber was recognized between 2004 through 2014 as one of Modern Healthcare’s 100 Most Influential People in US Healthcare.
Lieber previously served as CEO of the Emergency Nurses Association (ENA) for nearly nine years before accepting a position with the American Hospital Association as Vice President, Division of Personal Membership Groups. Prior experience includes Vice President of Operations for the Illinois Hospital Association; Senior Budget Analyst for the Illinois Bureau of the Budget; and Assistant Administrator, Research and Statistics for Arkansas Social Services.
Lieber holds an MA from the School of Social Service Administration at the University of Chicago, a BA in Psychology from the University of Arkansas, and has completed additional course work at the graduate schools of business at both universities and at the Keller Graduate School of Management. He is a Certified Association Executive (CAE) and a member of the American Society of Association Executives and Association Forum of Chicagoland and has been awarded honorary life memberships at the American Hospital Association and the American Society of Healthcare Risk Management.
Mark McClellan, MD, PhD
Senior Fellow and Director of the Initiatives on Value and Innovation in Health Care at the Brookings Institution
Dr. McClellan is a Senior Fellow and Director of the Initiatives on Value and Innovation in Health Care at the Brookings Institution. His work focuses on strategies and policy reforms to improve health care, including such areas as accountable care, better evidence from real-world practice, and more effective drug and device innovation.
A physician and economist by training, he also has a highly distinguished record in public service and in academic research. Dr. McClellan is a former administrator of the Centers for Medicare & Medicaid Services (CMS) and former commissioner of the U.S. Food and Drug Administration (FDA), where he developed and implemented major reforms in health policy. These include the Medicare prescription drug benefit, Medicare and Medicaid payment reforms, the FDA’s Critical Path Initiative, and public-private initiatives to develop better information on the quality and cost of care.
Dr. McClellan is the founding chair and a current board member of the Reagan-Udall Foundation for the FDA, is co-chair of the Quality Alliance Steering Committee and chairs the National Quality Forum’s partnership on clinician quality measurement. He is also a member of the Institute of Medicine, and is a research associate at the National Bureau of Economic Research. Additionally, Dr. McClellan has served as a member of the President’s Council of Economic Advisers and senior director for health care policy at the White House, and as Deputy Assistant Secretary for Economic Policy at the Department of the Treasury. He was previously an associate professor of economics and medicine with tenure at Stanford University, and has twice received the Kenneth Arrow Award for Outstanding Research in Health Economics.
McClellan holds an MD from the Harvard University–Massachusetts Institute of Technology (MIT) Division of Health Sciences and Technology, a PhD in economics from MIT, an MPA from Harvard University, and a BA from the University of Texas at Austin. He completed his residency training in internal medicine at Boston’s Brigham and Women's Hospital, is board-certified in Internal Medicine, and has been a practicing internist during his career.
David B. Nash, MD, MBA
Founding Dean of the Jefferson College of Population Health
Dr. Nash was named the Founding Dean of the Jefferson College of Population Health (formerly Jefferson School of Population Health) in 2008. He is also the Dr. Raymond C. and Doris N. Grandon Professor of Health Policy. Jefferson College of Population Health (JCPH) provides innovative educational programming designed to develop healthcare leaders for the future. Its offerings include Masters Programs in Population Health, Public Health, Healthcare Quality and Safety, Health Policy and Applied Health Economics and Outcomes Research. JCPH also offers a doctoral program in Population Health Sciences.
Dr. Nash is a board certified internist who is internationally recognized for his work in public accountability for outcomes, physician leadership development, and quality-of-care improvement. Repeatedly named to Modern Healthcare’s list of Most Powerful Persons in Healthcare, his national activities cover a wide scope. Currently he is on the Advisory Board of VHA’s Center for Applied Healthcare Studies. He is a principal faculty member for Quality of Care programming for the American Association for Physician Leadership, and leads the academic joint venture between the organization and the JCPH. He is on the National Quality Forum Task Force on Improving Population Health and is on the John M. Eisenberg Award Committee of the Joint Commission. Dr. Nash has chaired the Technical Advisory Group (TAG) of the Pennsylvania Health Care Cost Containment Council (HC4) for more than 15 years and he is widely recognized as a pioneer in the public reporting of outcomes.
Dr. Nash has governance responsibilities in both the not-for-profit and for-profit healthcare sector. He currently serves on the board of Main Line Health, a four-hospital system in suburban Philadelphia, PA. He is a member of the Board of Directors of the Population Health Alliance (PHA) and edits the official journal of the PHA. In the for-profit sector, Dr. Nash was named to the Board of Directors for Humana, Inc., one of the nation’s largest publically traded healthcare companies, in 2009. In October 2013 he joined the board of Vestagen Technical Textiles, a privately held advanced medical textile company in Orlando, FL and the board of InfoMC, a leading information technology company. He is on the Arsenal Capital Partners health care advisory board in New York City, NY.
Over the years, Dr. Nash has been recognized with many awards. Among the most recent are the Elliot Stone Award for leadership in public accountability for health data from NAHDO (2006); the Wharton Healthcare Alumni Achievement Award (2009); and the Joseph Wharton award in recognition of his “social impact” and the Philadelphia Business Journal’s medical educator innovation award (2012).
Dr. Nash’s publications include his “Nash on Health Policy” blog and an online column on MedPage Today, in addition to more than 100 articles in major peer-reviewed journals. He has edited 23 books, including Connecting with the New Healthcare Consumer, The Quality Solution, Demand Better, and most recently, Population Health: Creating a Culture of Wellness, (2nd edition). He is Editor-in-Chief of American Journal of Medical Quality, Population Health Management, P&T, and American Health & Drug Benefits (AHDB).
Dr. Nash received his BA in economics (Phi Beta Kappa) from Vassar College; his MD from the University of Rochester School of Medicine and Dentistry and his MBA in Health Administration (with honors) from the Wharton School at the University of Pennsylvania. While at Penn, he was a former Robert Wood Johnson Foundation Clinical Scholar and Medical Director of a nine-physician faculty group practice in general internal medicine.
Valinda Rutledge, MBA, MS
VP-Public Payor Health Strategy of Greenville Health System in
Valinda Rutledge is VP-Public Payor Health Strategy of Greenville Health System in South Carolina, where she is responsible for supporting the implementation of government initiatives such as ACOs and bundled payments. Ms. Rutledge, a well-respected healthcare executive known throughout the nation, is frequently sought after as a national speaker and consultant in the area of payment, clinical innovation, and population health.
Ms. Rutledge worked as a Senior Advisor and Group Director for the Patient Care Models Group within the Centers of Medicare and Medicaid Innovation (CMMI), where she led the development and roll-out of the Bundled Payment for Care Improvement Initiative, Strong Start perinatal care and other national programs. She also served on the Governance Committee that selected the grants for the $1 billion Health Care Innovation Challenge Grants, which focused on funding new programs of innovation and transformation in the healthcare industry at large.
Before joining CMS, Ms. Rutledge served as the Chief Executive Officer of CaroMont Health in Gastonia, NC, where she led the development of a 210-day bundled knee payment arrangement between CaroMont Health and North Carolina's largest health insurer, Blue Cross and Blue Shield of North Carolina. Prior to CaroMont Health, Ms. Rutledge was Chief Executive Officer of Bon Secours Saint Francis Health System in Greenville, SC. She was also Senior Vice President of the Bon Secours Health System with responsibility for system-wide physician alignment strategies, as well as market leader for both Kentucky and South Carolina. While at Bon Secours, she led the development of a groundbreaking partnership between Michelin of North America and Bon Secours, delivering chronic disease management with the pilot focusing on employees and members of their families with diabetes.
Ms. Rutledge holds a Master of Business Administration degree from Butler University in Indianapolis and a Master of Science degree in nursing from Wayne State University in Detroit.
James M. Schibanoff, MD
Consultant to Hearst Health
Dr. Schibanoff is a consultant to Hearst Health. He was the Editor-in-Chief of the Milliman Care Guidelines (now MCG) from 1998 until 2012. In that role, he supervised editorial and peer review of care guidelines and analysis of the evidence used to inform their development. He first joined Milliman, Inc., in 1996, where he was an Equity Principal. Prior to Milliman, Dr. Schibanoff served as the CEO of Sharp Memorial Hospital in San Diego (1993 to 1996) after practicing critical care medicine in San Diego for 18 years.
A graduate of Princeton University and the University of Southern California School of Medicine, Dr. Schibanoff completed a residency and chief residency in Internal Medicine and research fellowship in Pulmonary Disease at the University of California San Diego School of Medicine.
Mark D. Smith, MD, MBA
Professor of Clinical Medicine at the University of California at San Francisco
Dr. Smith is currently a Professor of Clinical Medicine at the University of California at San Francisco. He was a 2014 Menschel Senior Policy Fellow at the Harvard School of Public Health, and from 1996 through 2013 was the Founding President of the California HealthCare Foundation (CHCF). Smith helped build the Foundation into a recognized leader in delivery system innovation, public reporting of care quality, and applications of new technology in health care. Smith spearheaded the launch of California HealthLine and iHealthBeat, daily electronic publications with a combined circulation of 60,000; the CHCF Center for Healthcare Reporting at USC, an award-winning initiative which partners with local publications and broadcast outlets throughout the state in producing original reporting; the CHCF Innovation Fund, which invests in companies advancing the Foundation’s mission; and the CHCF Leadership Fellows Program, whose 300 alumni/ae are senior leaders in virtually every clinical enterprise in the state.
Smith is a nationally-recognized health policy expert. He has published over 50 articles in peer-reviewed journals and 25 book chapters and monographs. He has consulted for the governments of Kuwait, Denmark, and Singapore, and is a frequent keynote speaker, including for Microsoft, Health 2.0, and the Library of Congress.
Before founding CHCF, Dr. Smith was Executive Vice-President of the Henry J. Kaiser Family Foundation, where he oversaw programs in HIV, Reproductive Health, and the Health Care Marketplace. Prior to that, he was on the faculty at the Johns Hopkins Schools of Medicine and of Public Health, where he directed the AIDS clinic.
Dr. Smith was elected to the Institute of Medicine (IOM) in 2001. He chaired the IOM’s Committee on the Learning Healthcare System, which produced the widely-publicized 2012 report Best Care at Lower Cost. He serves on the Boards of the Institute for Healthcare Improvement, the Commonwealth Fund, the Archstone Foundation, and the Editorial Board of Health Affairs. He has served as a Director of Tibion, Inc. and the National Business Group on Health. He has been honored by the California Legislature, the California Hospital Association, Grantmakers in Health, the Society of General Internal Medicine and others.
Dr. Smith holds a BA from Harvard College, an MD from the University of North Carolina, and an MBA from the Wharton School at the University of Pennsylvania. A Board-certified internist, he maintains an active clinical practice in HIV care at San Francisco General Hospital.